Clik here to view.
Poly sitting pretty after taking funding haul to $70m
Cambridge University spin-out PolyAI, which provides enterprise voice assistants, has raised $40 million in a Series B funding round.It was led by Georgian with participation from Twilio Ventures as...
View ArticleClik here to view.
Darktrace defiant despite shares shock after Thoma Bravo cold shoulder
Cyber security specialist Darktrace is toughing out a transformative stage of its relatively young life after US private equity firm Thoma Bravo decided not to make a takeover bid – prompting a 33 per...
View ArticleClik here to view.
Bicycle Therapeutics puts Life Sciences in the vanguard as Business of the Year
Life sciences pioneer Bicycle Therapeutics was last night named as champion company at the Business Weekly Awards at Queens’ College in Cambridge.It became the first Life Science company in the...
View ArticleClik here to view.
Abcam takes off in anticipation of NASDAQ solo flight
Cambridge company Abcam, which supplies life science research tools globally, saw its UK share price take-off after posting an excellent set of interim results for the six months to June 30.The company...
View ArticleClik here to view.
TTP subsidiary acquired by The Lee Company
Another Cambridge Cluster tech company has been devoured by a US buyer after The Lee Company in Connecticut swooped to acquire TTP Ventus Ltd from TTP Group for an undisclosed sum.TTP Ventus is an...
View ArticleClik here to view.
Pam Garside named first woman chair of Cambridge Angels
Healthcare specialist Pam Garside has been named as the first woman chair of Cambridge Angels. From October 1 she succeeds Simon Thorpe whose three-year tenure ends. He will remain on the Angels’...
View ArticleClik here to view.
Jeff Bridges helps AstraZeneca flag lingering peril of Covid-19
Cambridge Big Biotech AstraZeneca and Oscar winning actor Jeff Bridges have teamed up to launch a new campaign – Up The Antibodies – that embraces the reality for millions of immunocompromised...
View ArticleClik here to view.
Cambridge opens UK’s first institute dedicated to early cancer research
Today sees the launch of the Early Cancer Institute (ECI) at the University of Cambridge which aims to help create a world where we can detect cancer early enough to cure it.It is the first physical...
View ArticleClik here to view.
Game on as Frontier Developments hints at fresh blockbusters
Cambridge video games company Frontier Developments saw its stock nosedive then rocket in a dramatic day on AIM as shareholders eventually realised the huge potential set to be unveiled.With shares...
View ArticleClik here to view.
Arm strengthens board ahead of ‘prospective IPO’
Arm has unveiled a new CFO and fortified its board ahead of what chief executive Rene Haas calls “a prospective IPO.”The Cambridge superchip architect seems set on a US float early in 2023 despite...
View ArticleClik here to view.
Plenty of dough as Cambridge duo back Pretzel’s $72.5m Series A
Cambridge Innovation Capital and the university’s tech transfer body Cambridge Enterprise have injected capital into a monster $72.5 million Series A round for a newly-launched biotech pioneer...
View ArticleClik here to view.
Alloy shows its mettle with $42m Series D raise
Alloy Therapeutics, a transatlantic bio business which has a Cambridge operation at Granta Park, has raised $42 million Series D cash to underpin a new phase of expansion.The round was led by existing...
View ArticleClik here to view.
Porotech unveils world first nextgen display technology
Porotech, a global leader in microLED and Gallium Nitride (GaN) semiconductor technology, has launched the world’s first public demonstration of an ‘all-in-one’ full-colour display of microLED pixels....
View ArticleClik here to view.
Arm shuffles leadership pack to deal more aces
Cambridge superchip architect Arm has ramped up its evolution strategy with changes to how some of its most important teams operate. Working on the mantra that ‘change drives innovation,’ CEO Rene Haas...
View ArticleClik here to view.
Enhanc3D raises £10m to boost Cambridge genomics capability
Functional genomics company Enhanc3D has raised £10 million in Series A money to accelerate the development of its proprietary technology platform – GenLink3DTM – from its Cambridge HQ.The company is...
View ArticleClik here to view.
Empryean raises $22m and launches genetic engineering platform
Genetic engineering company Empyrean Neuroscience, Inc., has launched with a $22 million Series A financing and a genetic engineering platform to advance a pipeline of neuroactive compounds targeting...
View ArticleClik here to view.
US energy tech giant pumps £12m into Cambridge’s Levidian
Cambridge-based Levidian’s vision of a decarbonised world powered by hydrogen and built on graphene has received a powerful endorsement via a £12 million investment from US energy technology giant...
View ArticleClik here to view.
Nothing lax about Lex as it thrives among academic elite
Louise Chapman, Managing Editor of Cambridge startup Lex Academic, offers the inside track on how the company has grown since foundation in November 2021. It is now around three times the size in...
View ArticleClik here to view.
Businesses demand US flights and more Asia services from Stansted in £185...
New research conducted by London Stansted and Cambridge& reveals that £185 million in fresh investment could be unlocked with the introduction of new US routes from the airport.Businesses across...
View ArticleClik here to view.
Jagex records its highest ever revenue
Cambridge video game developer and publisher Jagex has reached its highest ever revenue since foundation in 2001.Revenue for 2021 hit £124.86 million – up four per cent on 2020 – and represented the...
View Article